31
Participants
Start Date
September 30, 2002
Primary Completion Date
June 30, 2007
Study Completion Date
June 30, 2007
PF-3512676
PF-3512676 IV at doses: 0.01mg/kg, 0.16mg/kg and 0.32mg/kg PF-3512676 Injection given by subcutaneous injection at doses: 0.04mg/kg, 0.16mg/kg, 0.20mg/kg, 0.28mg/kg, 0.32mg/kg, 6mg, 10mg, 40mg.
Pfizer Investigational Site, Asheville
Pfizer Investigational Site, Plantation
Pfizer Investigational Site, Fort Myers
Pfizer Investigational Site, Port Charlotte
Pfizer Investigational Site, Cape Coral
Pfizer Investigational Site, Naples
Pfizer Investigational Site, Bonita Springs
Pfizer Investigational Site, Bradenton
Pfizer Investigational Site, Sarasota
Pfizer Investigational Site, Venice
Pfizer Investigational Site, Venice
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Collierville
Pfizer Investigational Site, Olive Branch
Pfizer Investigational Site, Oxford
Pfizer Investigational Site, Vincennes
Pfizer Investigational Site, Ann Arbor
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Palm Springs
Pfizer Investigational Site, Stanford
Pfizer Investigational Site, Berkely
Pfizer Investigational Site, Gilroy
Pfizer Investigational Site, Hollister
Pfizer Investigational Site, Portland
Pfizer Investigational Site, New Haven
Pfizer Investigational Site, Fort Myers
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Livingston
Lead Sponsor
Pfizer
INDUSTRY